Invitation to Elekta’s nine-month interim report conference call
Elekta’s nine-month interim report for 2011/12 will be published on March 5, 2012 with the following schedule:
- The report will be published at 07.30 CET.
- Elekta will host a telephone conference at 10.00-11.00 CET, with President and CEO Tomas Puusepp and CFO Håkan Bergström.
To take part in the conference call, please dial in about 5-10 minutes in advance and use the access code 911604.
- Swedish dial-in number: +46 (0)8 5052 0110
- UK dial-in number: +44 (0)20 7162 0077
- US dial-in number: + 1 334 323 6201
The telephone conference will also be broadcasted over the Internet (listen only). Please use the link http://webeventservices.reg.meeting-stream.com/58403_elekta/
For further information, please contact: Johan Andersson Melbi, Investor Relations Manager, Elekta AB +46 702 100 451, firstname.lastname@example.org.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.